Evidence map›Paper›PMID 31069154›Full record

ArticleOncoimmunology

Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer.

Livius Penter, Kerstin Dietze, Julia Ritter, Maria Fernanda Lammoglia Cobo, Josefin Garmshausen, Felix Aigner, Lars Bullinger, Holger Hackstein, Sandra Wienzek-Lischka, Thomas Blankenstein and 3 more

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Is an Immunosuppressive Microenvironment a Characteristic of Both Intra- and Extraparenchymal Central Nervous Tumors?Pathophysiology : the official journal of the International Society for Pathophysiology · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Livius PenterDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany.ORCID 0000-0002-9060-0207
Kerstin DietzeDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany.
Julia RitterInstitute for Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Maria Fernanda Lammoglia CoboDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany.ORCID 0000-0002-0369-0364
Josefin GarmshausenDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany.
Felix AignerDepartment of Surgery, Charité - Universitätsmedizin Berlin (CCM and CVK), Berlin, Germany.
Lars BullingerDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany.
Holger HacksteinTransfusion Medicine, University Hospital Erlangen, Erlangen, Germany.
Sandra Wienzek-LischkaInstitute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Giessen, Germany.
Thomas BlankensteinBerlin Institute of Health (BIH), Berlin, Germany.
Michael HummelInstitute for Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Klaus DornmairInstitute of Clinical Neuroimmunology, Biomedical Center and Hospital of the LMU, Munich, Germany.
Leo HansmannDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany.ORCID 0000-0003-3790-0128
Charité - Universitätsmedizin Berlin · DEGerman Cancer Society · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEJustus-Liebig-Universität Gießen · DELMU Klinikum · DEMax Delbrück Center · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The degree and type of T cell infiltration influence rectal cancer prognosis regardless of classical tumor staging. We asked whether clonal expansion and tumor infiltration are restricted to selected-phenotype T cells; which clones are accessible in peripheral blood; and what the spatial distribution of their target antigens is. From five rectal cancer patients, we isolated paired tumor-infiltrating T cells (TILs) and T cells from unaffected rectum mucosa (T

Indexed as

cancer immunologyclonal T cell expansionhuman immunologyRectal cancersingle cell immune phenotypingsingle cell technologiesT cell antigen specificityT cell receptor sequencingtumor-infiltrating lymphocytes

Identifiers

PMID31069154
PMCPMC6492980
OpenAlexW2923555931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.